CPHI Online is the largest global marketplace in the pharma ingredients industry

  • Products
    0
  • Companies
    0
  • Articles
    0
  • Events
    0
  • Webinars
    0

EDEDAY – EDENIGHT: HYPERTONIC 0.4% HYALURONIC ACID (OPHTHALMOLOGY - CORNEAL EDEMA)

EDEDAY – EDENIGHT: HYPERTONIC 0.4% HYALURONIC ACID (OPHTHALMOLOGY - CORNEAL EDEMA)
Product Description

Ededay and Edenight are hypertonic products containing sodium hyaluronate 0.4% and hypertonic agents, indicated for the temporary relief of the symptoms of corneal edema. Ededay eye drops also contains sorbitol (13,5%) and can be used during the day.          Edenight ointment contains sodium chloride (4.5%) and is suitable for a night application. The application results into an increased saline concentration of tear film and consequently a recall of water from the corneal layers towards the surface.  Sodium hyaluronate provides protection and hydration and makes the application of hypertonic ointment more comfortable. Ededay and Edenight can help to accelerate postoperative recovery, with a reduction in corneal edema and an improvement in visual function.
- Presentation: 10ml Novelia bottle; 5 gr Tube.
- Class: Medical Device
- CE Mark expiry date: 2024

4 Scientific publication available

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
Specifications

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

More Products from NTC S.r.l. (29)

NTC S.r.l. resources (1)

  • Brochure Therapeutical areas - brochure

    Advanced scientific research and technology drive our efforts to innovate care practices.
    Our range of products builds from our historical vocation for innovation aimed at improving the experience of patients and healthcare practices.
    An innovation aimed at discovering specific therapeutic gestures: simple and intuitive,  sustainable, and technically advanced for empowering the patient.
    Our research aims to put pioneering new products within the reach of everyone and to optimize the
    performance of our products by analyzing the daily needs and habits of people undergoing treatment.
    We research, develop and produce innovative drugs, medical devices and food supplements.
    We market our products worldwide through licensing, distribution, marketing, and commercial deals with partner companies.
    Our core therapeutic areas are: Ophthalmology, Gastro-Metabolism, Pediatrics and Gynacology.